Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 4, 2013, Pages

  Turner, Hugo C ^a   Churcher, Thomas S ^a   Walker, Martin ^a   Osei Atweneboana, Mike Y ^b   Prichard, Roger K ^c   Basáñez, María Gloria ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CSIR WATER RESEARCH INSTITUTE   (Ghana)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ARTICLE; DISEASE ELIMINATION; DRUG EFFICACY; FEMALE; FERTILITY; HEALTH CARE NEED; HUMAN; MASS IMMUNIZATION; MATHEMATICAL MODEL; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CLEARANCE; PARASITE LOAD; PARASITE TRANSMISSION; PATIENT ATTITUDE; SIMULIUM DAMNOSUM; TREATMENT OUTCOME;

EID: 84876872489     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002169     Document Type: Article

References (64)

1. Duke BOL, (1990) Human onchocerciasis-an overview of the disease. Acta Leiden 59: 9-24.
2. Bradley JE, Whitworth J, Basáñez MG (2005) Onchocerciasis. In: Wakelin D, Cox F, Despommier D, Gillespie, Eds.Topley and Wilson's Microbiology and Microbial Infections. Volume Parasitology. 10th edition. London: Hodder Arnold, pp: 781-801.
3. Kirkwood B, Smith P, Marshall T, Prost A, (1983) Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg 77: 862-868.
4. Little MP, Breitling LP, Basáñez MG, Alley ES, Boatin BA, (2004) Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 363: 1514-1521.
5. Walker M, Little MP, Wagner KS, Soumbey-Alley EW, Boatin BA, et al. (2012) Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality. PLoS Negl Trop Dis 6: e1578.
6. Meredith SEO, Dull HB, (1998) Onchocerciasis: the first decade of Mectizan (trademark) treatment. Parasitol Today 14: 472-474.
7. Molyneux DH, (1995) Onchocerciasis control in West Africa: current status and future of the onchocerciasis control programme. Parasitol Today 11: 399-402.
8. Richards FO Jr, Boatin B, Sauerbrey M, Sékétéli A, (2001) Control of onchocerciasis today: status and challenges. Trends Parasitol 17: 558-563.
9. Remme JH, (1995) The African Programme for Onchocerciasis Control: preparing to launch. Parasitol Today 11: 403-406.
10. Sékétéli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, et al. (2002) The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (Suppl 1) pp. S15-S28.
11. Amazigo U, (2008) The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008 102: 19-22.
12. African Programme for Onchocerciasis Control (APOC) (2010) Report of the 29th session of the Technical Consultative Committee (TCC), Ouagadougou, 14-19 September 2009. World Health Organization. Available: http://www.who.int/apoc/about/structure/tcc/TCC29_FINAL_REPORT_Eng.pdf. Accessed 19th March 2013.
13. World Bank (2012) Pushing back Neglected Tropical Diseases in Africa. Available: http://www.worldbank.org/en/news/feature/2012/11/17/pushing-back-neglected-tropical-diseases-in-africa. Accessed 19th March 2013.
14. Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK, (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021-2029.
15. Ndyomugyenyi R, Lakwo T, Habomugisha P, Male B, (2007) Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward. Ann Trop Med Parasitol 101: 323-333.
16. Ministry of Health, Republic of Uganda (2007) National Plan 2007-2010. Integrated Control of Neglected Tropical Diseases in Uganda. Available: http://ntd.rti.org/about/index.cfm?fuseaction=static&label=uganda. Accessed 19th March 2013.
17. Basáñez MG, Pion SDS, Boakes E, Filipe JAN, Churcher TS, et al. (2008) Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 8: 310-322.
18. Duke BOL, Zea-Flores G, Muñoz B, (1991) The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol 42: 175-180.
19. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, et al. (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497.
20. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, et al. (2012) Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors 5: 28.
21. African Programme for Onchocerciasis Control (2010) Conceptual and Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment. WHO/APOC. Available: http://www.who.int/apoc/oncho_elimination_report_english.pdf. Accessed 19th March 2013.
22. Plaisier AP, van Oortmarssen GJ, Habbema JDF, Remme JH, Alley ES, (1990) ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed 31: 43-56.
23. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJD, van Oortmarssen G, et al. (2002) Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ 80: 384-391.
24. Alley ES, Plaisier AP, Boatin BA, Dadzie KY, Remme J, et al. (1994) The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg 88: 581-584.
25. Plaisier AP, Alley ES, Boatin BA, Van Oortmarssen GJ, Remme H, et al. (1995) Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis 172: 204-210.
26. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, et al. (1992) Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg 47: 156-169.
27. Bottomley C, Isham V, Collins RC, Basáñez MG, (2008) Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology 135: 1571-1581.
28. Kläger S, Whitworth JA, Post RJ, Chavasse DC, Downham MD, (1993) How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol 44: 305-310.
29. Kläger SL, Whitworth JA, Downham MD, (1996) Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Trop Med Int Health 1: 581-589.
30. Filipe JAN, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, et al. (2005) Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A 102: 15265-15270.
31. Churcher TS, Basáñez MG, (2009) Sampling strategies to detect anthelmintic resistance: the perspective of human onchocerciasis. Trends Parasitol 25: 11-17.
32. Basáñez MG, Boussinesq M, (1999) Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci 354: 809-826.
33. Schulz-Key H, Kläger S, Awadzi K, Diallo S, Greene BM, et al. (1985) Treatment of human onchocerciasis: the efficacy of ivermectin on the parasite. Trop Med Parasitol (Suppl 2) pp. 20.
34. Albiez EJ, Walter G, Kaiser A, Ranque P, Newland HS, et al. (1988) Histological examination of onchocercomata after therapy with ivermectin. Trop Med Parasitol 39: 93-99.
35. Osei-Atweneboana MY, Boakye DA, Awadzi K, Gyapong JO, Prichard RK, (2012) Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment. Int J Parasitol: Drugs Drug Resistance 2: 20-28.
36. Brieger WR, Okeibunor JC, Abiose AO, Wanji S, Elhassan E, et al. (2011) Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria. Parasit Vectors 4: 152.
37. Anderson J, Fuglsang H, Hamilton PJS, Marshall TF de C, (1974) Studies on onchocerciasis in the United Cameroon Republic II. Comparison of onchocerciasis in rain-forest and Sudan-savanna. Trans R Soc Trop Med Hyg 68: 209-222.
38. Renz A, Fuglsang H, Anderson J, (1987) Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon IV. The different exposure to Simulium bites and transmission of boys and girls and men and women, and the resulting manifestations of onchocerciasis. Ann Trop Med Parasitol 81: 253-262.
39. Basáñez MG, Churcher TS, Grillet ME, (2009) Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol 68: 263-313.
40. Duke BOL, Anderson J, Fuglsang H, (1975) The Onchocerca volvulus transmission potentials and associated patterns of onchocerciasis at four Cameroon Sudan-savanna villages. Tropenmed Parasitol 26: 143-154.
41. Renz A, Wenk P, (1987) Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon I. Prevailing Simulium vectors, their biting rates and age-composition at different distances from their breeding sites. Ann Trop Med Parasitol 81: 215-228.
42. Prost A, Hervouet JP, Thylefors B, (1979) Les niveaux d'endémicité dans l'onchocercose. Bull World Health Organ 57: 655-662.
43. Remme JH, Ba O, Dadzie KY, Karam M, (1986) A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 64: 667-681.
44. Basáñez MG, McCarthy JS, French MD, Yang GJ, Walker M, et al. (2012) A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis 6: e1548.
45. Duke BOL, Zea-Flores G, Castro J, Cupp EW, Muñoz B, (1991) Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 45: 132-137.
46. Chavasse DC, Post RJ, Davies JB, Whitworth JA, (1993) Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Trop Med Parasitol 44: 155-158.
47. Cupp EW, Duke BOL, Mackenzie CD, Rumbea Guzmán J, Vieira JC, et al. (2004) The effects of long-term community level treament with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 71: 602-607.
48. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, et al, (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360: 203-210.
49. Duke BOL, (2005) Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology 130: 447-453.
50. Prost A, Prod'hon J, (1978) Le diagnostique de l'onchocercose: revue critique des méthodes en usage. Méd Trop (Mars) 38: 519-532.
51. Pion SDS, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, et al. (2013) Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multi-treated population from Cameroon. PLoS Negl Trop Dis 7: e2084.
52. Duerr HP, Raddatz G, Eichner M, (2011) Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol 41: 581-589.
53. Basáñez MG, Ricárdez-Esquinca J, (2001) Models for the population biology and control of human onchocerciasis. Trends Parasitol 17: 430-438.
54. Rodríguez-Pérez MA, Unnasch TR, Domínguez-Vázquez A, Morales-Castro AL, Peña-Flores GP, et al. (2010) Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico. Am J Trop Med Hyg 83: 21-27.
55. Little MP, Basáñez MG, Breitling LP, Boatin BA, Alley ES, (2004) Incidence of blindness during the Onchocerciasis Control Programme in Western Africa, 1971-2002. J Infect Dis 189: 1932-1941.
56. Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, et al. (2010) A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLoS Negl Trop Dis 4: e640.
57. Brieger WR, Okeibunor JC, Abiose AO, Ndyomugyenyi R, Wanji S, et al. (2012) Characteristics of persons who complied with and failed to comply with annual ivermectin treatment. Trop Med Int Health 17: 920-930.
58. Traoré S, Wilson MD, Sima A, Barro T, Diallo A, et al. (2009) The elimination of the onchocerciasis vector from the island of Bioko as a result of larviciding by the WHO African Programme for Onchocerciasis Control. Acta Trop 111: 211-218.
59. Garms R, Lakwo TL, Ndyomugyenyi R, Kipp W, Rubaale T, et al. (2009) The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding. Acta Trop 111: 203-210.
60. May RM, Woolhouse ME, (1993) Biased sex ratios and parasite mating probabilities. Parasitology 107: 287-295.
61. Basáñez MG, French MD, Walker M, Churcher TS, (2012) Paradigm lost: how parasite control may alter pattern and process in human helminthiases. Trends Parasitol 28: 161-171.
62. Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, García HH, et al. (2012) A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6: e1549.
63. McCarthy JS, Lustigman S, Yang GJ, Barakat RM, García HH, et al. (2012) A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis 6: e1601.
64. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, et al. (2012) Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis 6: e1825.